Sugammadex operates through a unique mechanism of action. It binds tightly to aminosteroid muscle relaxants, forming a complex that is subsequently excreted from the body. This process is known as encapsulation, and it is both rapid and specific to the drugs it targets, leading to a quicker and more predictable reversal of muscle relaxation compared to traditional agents like neostigmine.